⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL269058 | 0.80 | — | — | |
| SCHEMBL51848 | 0.78 | — | — | |
| SCHEMBL11430726 | 0.77 | — | — | |
| SCHEMBL9930648 | 0.75 | — | — | |
| SCHEMBL22975 | 0.73 | — | — | |
| SCHEMBL114502 | 0.73 | — | — | |
| SCHEMBL48154 | 0.73 | — | — | |
| SCHEMBL28505758 | 0.72 | — | — | |
| SCHEMBL51681 | 0.71 | — | — | |
| SCHEMBL26776 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 62 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113412310-B | Composition for optical measurement technology applications | F2MB-工程公司(有限责任) | 2024-07-09 | — | — | CN | claimed |
| CN-116368009-A | Photocurable resin composition for three-dimensional modeling and method for preparing three-dimensional object | 佳能株式会社 | 2023-06-30 | — | — | CN | disclosed |
| CN-111039774-A | Process for producing aliphatic carboxylic acid compound and pyridine compound adduct of aliphatic ketone compound | 捷恩智株式会社 | 2020-04-21 | — | — | CN | disclosed |
| US-20170137387-A1 | PHARMACOLOGICALLY ACTIVE QUINAZOLINEDIONE DERIVATIVES | ORION CORPORATION (FI) | 2017-05-18 | — | — | US | disclosed |
| EP-3140301-A1 | PHARMACOLOGICALLY ACTIVE QUINAZOLINEDIONE DERIVATIVES | Orion Corporation (FI) | 2017-03-15 | — | — | EP | disclosed |
| CN-106414430-A | Pharmacologically active quinazolinedione derivatives | 奥赖恩公司 | 2017-02-15 | — | — | CN | disclosed |
| CN-103442712-B | Substituted 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals | SAI NUOFEI (FR) | 2016-01-20 | — | — | CN | disclosed |
| CN-103459374-B | Amino-substituted 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals | SAI NUOFEI (FR) | 2015-11-25 | — | — | CN | disclosed |
| WO-2015169999-A1 | PHARMACOLOGICALLY ACTIVE QUINAZOLINEDIONE DERIVATIVES | ORION CORPORATION (FI) | 2015-11-12 | — | — | WO | disclosed |
| CN-102884052-B | O-substituted 3-heteroaroylamino-propionic acid derivatives and their pharmaceutical use | SAI NUOFEI (FR) | 2015-10-21 | — | — | CN | disclosed |
| EP-1987015-A2 | BENZOYL-SUBSTITUTED ALANINES | BASF SE (DE) | 2008-11-05 | — | — | EP | disclosed |
| US-20080200338-A1 | Heteroaroyl-Substituted Serineamides | BASF AKTIENGESELLSCHAFT (DE) | 2008-08-21 | — | — | US | disclosed |
| US-20080200542-A1 | Benzoyl-Substituted Serineamides | BASF AKTIENGESELLSCHAFT (DE) | 2008-08-21 | — | — | US | disclosed |
| WO-2008084073-A1 | HETEROARYL-SUBSTITUTED SERINE AMIDES | BASF SE (DE) | 2008-07-17 | — | — | WO | disclosed |
| WO-2008084070-A1 | BENZOYL-SUBSTITUTED SERINE AMIDES | BASF SE (DE) | 2008-07-17 | — | — | WO | disclosed |
| EP-1888509-A1 | BENZOYL-SUBSTITUTED SERINE AMIDES | BASF AKTIENGESELLSCHAFT (DE) | 2008-02-20 | — | — | EP | disclosed |
| WO-2007134971-A1 | BENZOYL-SUBSTITUTED ALANINES | BASF SE (DE) | 2007-11-29 | — | — | WO | disclosed |
| WO-2007093529-A2 | HETEROAROYL-SUBSTITUTED ALANINES | BASF SE (DE) | 2007-08-23 | — | — | WO | disclosed |
| WO-2007093539-A2 | BENZOYL-SUBSTITUTED ALANINES | BASF SE (DE) | 2007-08-23 | — | — | WO | disclosed |
| WO-2006125688-A1 | BENZOYL-SUBSTITUTED SERINE AMIDES | BASF AKTIENGESELLSCHAFT (DE) | 2006-11-30 | — | — | WO | disclosed |